Missouri Pharmacy Board Regulations: Telehealth Prescribing, Compounding, and Fulfillment Compliance

The landscape of healthcare delivery continues to evolve, with telehealth playing an increasingly prominent role. As healthcare businesses expand their services into Missouri, it is critical to understand the state's specific regulations governing pharmacy practice, particularly as they pertain to prescriptions originating from telehealth encounters, compounding, and medication fulfillment. The Missouri Board of Pharmacy is the primary regulatory body responsible for licensing and regulating pharmacists, pharmacies, and drug distributors within the state, ensuring the safe and effective delivery of pharmaceutical care.

Authority of the Missouri Board of Pharmacy

The Missouri Board of Pharmacy operates under the authority granted by Chapter 338 of the Missouri Revised Statutes, specifically RSMo §338.010 et seq., and its corresponding administrative rules found in 20 CSR 2220. These statutes and rules define what constitutes a valid prescription, the requirements for dispensing and compounding medications, and the responsibilities of pharmacists and pharmacies. While the Missouri Board of Registration for the Healing Arts (MBRHA) primarily regulates the practice of medicine, its rules often intersect with pharmacy regulations, especially concerning the validity of telehealth-originated prescriptions.

Telehealth Prescribing Requirements

For a prescription to be valid and legally dispensed by a Missouri-licensed pharmacy, it must meet specific criteria, regardless of whether it originated from an in-person visit or a telehealth consultation. Key considerations for telehealth prescribing include:

• Valid Patient-Practitioner Relationship: Missouri law, particularly RSMo §191.1140, generally requires a proper patient-practitioner relationship to be established before a controlled substance can be prescribed via telehealth. While the federal Ryan Haight Act waiver during the COVID-19 Public Health Emergency allowed for prescribing controlled substances without an initial in-person exam, state laws often have their own requirements for a valid relationship, even for non-controlled substances. The MBRHA's rules on telehealth (20 CSR 2150-2.120) emphasize that the standard of care for telehealth must be equivalent to that of an in-person encounter.
• Prescription Content: All prescriptions, including those from telehealth, must contain specific information as outlined in 20 CSR 2220-2.010(1), such as the patient's full name and address, the prescriber's full name, address, and DEA number (if applicable), drug name, strength, dosage form, quantity, directions for use, and date issued. Electronic prescriptions must comply with federal and state standards for e-prescribing.
• Controlled Substances: Prescribing controlled substances via telehealth remains a complex area. While the DEA's proposed rules for telehealth prescribing of controlled substances are still pending, Missouri's existing statutes and the MBRHA's rules must be carefully followed. An initial in-person examination or a referral from a practitioner who has conducted one is typically required for controlled substances, absent specific waivers or exceptions.

Compounding Regulations for Telehealth

Compounding pharmacies play a vital role in providing customized medications. However, Missouri has strict regulations governing compounding, particularly to distinguish between legitimate patient-specific compounding and manufacturing. These rules are crucial for medspas, functional medicine practices, and other specialties that frequently utilize compounded preparations.

• Patient-Specific Prescriptions: Compounded medications must be prepared for an individual patient based on a valid, patient-specific prescription. RSMo §338.220 and 20 CSR 2220-2.060 detail the requirements for compounding. Pharmacies are generally prohibited from compounding large quantities of drugs in anticipation of receiving prescriptions, except in limited circumstances for a pharmacist-patient relationship or in response to a valid prescription order.
• Office Use Compounding: Missouri generally prohibits compounding for